MASSDEVICE ON CALL — Tech titan Apple (NSDQ:AAPL) made some recent changes to its app-developer guidelines in order to protect patient data collected through its highly anticipated HealthKit platform, slated to hit the market later this year.
New language in the developer rules state that app-providers may not "sell an end-user’s health information collected through the HealthKit API to advertising platforms, data brokers or information resellers," according to a report from the Financial Times.
The move may help squash some of the privacy concerns about growing use of phone-based health, wellness and medical apps. The coming HealthKit system will collect data from a variety of healthcare apps, synthesizing the data in one program and allowing developers to build products that use information gathered by other programs, if users grant permission to share data between apps.
Long-distance check-ups to hit 16M next year
Telehealth analysts estimate that the number of long-distance video-based physician consultations will surpass 16 million in 2015 and 130 million in 2018.
Stryker heads to Boston on golf tour
Orthopedics giant Stryker (NYSE:SYK) is on its way to Boston for the Deutsche Bank Championship as the official joint replacements company of the PGA Tour.
What about women?
Medical journals are beginning to require that clinical researchers report the sex of animals and cells used in studies in order to draw attention to the fact that "surgical researchers rarely use female animals or female cells in their published studies – despite a huge body of evidence showing that sex differences can play a crucial role in medical research."
Analyst cools on Boston Scientific’ stock
TheStreet analyst Richard Saintvilus advises investors to avoid Boston Scientific’s (NYSE:BSX) shares, saying that the stock has underperformed compared to some of its peers.